Companies / Omeros Corp / Activity
Activity — Omeros Corp
17 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Demopulos Gregory A MD CEO | Other | Common stock | $4.27M | -358K -19.58% | 1,469,308 2.03% of shares | low |
| Feb 18, 2026 | Demopulos Gregory A MD CEO | Exercise | Common stock | $4.11M | +400K +28.03% | 1,826,986 2.52% of shares | low |
| Jan 12, 2026 | Borges David J. Executive | Sell | Common stock | $381.6K | -30K -100.00% | 0 0.00% of shares | medium |
| Jan 13, 2026 | Borges David J. Executive | Sell | Common stock | $369.3K | -30K -100.00% | 0 0.00% of shares | medium |
| Jan 13, 2026 | Borges David J. Executive | Exercise | Common stock | $91.8K | +30K | 30,000 0.04% of shares | low |
| May 22, 2026 | Cable Thomas J. Director | Sell | Common Stock | $87.0K | -8K -17.62% | 35,067 0.05% of shares | low |
| May 22, 2026 | Cable Thomas J. Director | Exercise | Common Stock | $81.3K | +8K +21.39% | 42,567 0.06% of shares | low |
| Jun 18, 2026 | Shah Rajiv Director | Grant | Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| Jun 18, 2026 | Perkinson Diana T. Director | Grant | Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| Jun 18, 2026 | Hood Leroy E. MD PhD Director | Grant | Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| Jun 18, 2026 | Demopulos Peter A MD Director | Grant | Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| Jun 18, 2026 | Cable Thomas J. Director | Grant | Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| Jun 18, 2026 | Bumol Thomas F. Director | Grant | Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| May 22, 2026 | Cable Thomas J. Director | Exercise | Stock Option (Right to Buy) | — | -8K -100.00% | 0 0.00% of shares | low |
| Jun 18, 2026 | Hanish Arnold C Director | Grant | Stock Option (Right to Buy) | — | +15K | 15,000 0.02% of shares | low |
| Feb 18, 2026 | Demopulos Gregory A MD CEO | Exercise | Stock option (right to buy) | — | -400K -100.00% | 0 0.00% of shares | low |
| Jan 13, 2026 | Borges David J. Executive | Exercise | Stock Option (right to buy) | — | -30K -31.58% | 65,000 0.09% of shares | low |